Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases

Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases

Non-alcoholic fatty acid liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) are the fatal liver diseases which encompass a spectrum of disease severity associated with increased risk of type 2 diabetes mellitus (T2DM), a metabolic disorder. Heat shock prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular biotechnology 2024-08
Hauptverfasser: Nithyasree, V, Magdalene, P, Praveen Kumar, P K, Preethi, J, Gromiha, M Michael
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Molecular biotechnology
container_volume
creator Nithyasree, V
Magdalene, P
Praveen Kumar, P K
Preethi, J
Gromiha, M Michael
description Non-alcoholic fatty acid liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) are the fatal liver diseases which encompass a spectrum of disease severity associated with increased risk of type 2 diabetes mellitus (T2DM), a metabolic disorder. Heat shock proteins serve as markers in early prognosis and diagnosis of early stages of liver diseases associated with metabolic disorder. This review aims to comprehensively investigate the significance of HSP90 isoforms in T2DM and liver diseases. Additionally, we explore the collective knowledge on plant-based drug compounds that regulate HSP90 isoform targets, highlighting their potential in treating T2DM-associated liver diseases. Furthermore, this review focuses on the computational systems' biology and next-generation sequencing technology approaches that are used to unravel the potential medicine for the treatment of pleiotropy of these 2 diseases and to further elucidate the mechanism.
doi_str_mv 10.1007/s12033-024-01251-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3094826878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3094826878</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-60db7836f19eb395600b02d2c374e2f128067c3f72bc210a2aa6b9910139fa473</originalsourceid><addsrcrecordid>eNpNUMlOwzAUtBCIlsAPcEA-cgm8ZydOfKzK0kpFbOUc2YkjjNIk5Dmg_j2VKBKnmcNsGsbOEa4QILsmFCBlDCKJAUWKMR6wKaapjkFCeviPT9gJ0QeAwDSRx2wiNSqhQU_Z80vXON7VfPH6pIH7lq-3veOC33hjXXDEH1zT-DASN23Fl4H4jKgrvQm-a_m3D-985b_csDOQM-TolB3VpiF3tseIvd3drueLePV4v5zPVnGPCYZYQWWzXKoatbNSpwrAgqhEKbPEiRpFDiorZZ0JWwoEI4xRVmsElLo2SSYjdvmb2w_d5-goFBtP5W6saV03UiFBJ7lQ-a4kYhd76Wg3rir6wW_MsC3-bpA_ik1clg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3094826878</pqid></control><display><type>article</type><title>Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases</title><source>SpringerNature Journals</source><creator>Nithyasree, V ; Magdalene, P ; Praveen Kumar, P K ; Preethi, J ; Gromiha, M Michael</creator><creatorcontrib>Nithyasree, V ; Magdalene, P ; Praveen Kumar, P K ; Preethi, J ; Gromiha, M Michael</creatorcontrib><description>Non-alcoholic fatty acid liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) are the fatal liver diseases which encompass a spectrum of disease severity associated with increased risk of type 2 diabetes mellitus (T2DM), a metabolic disorder. Heat shock proteins serve as markers in early prognosis and diagnosis of early stages of liver diseases associated with metabolic disorder. This review aims to comprehensively investigate the significance of HSP90 isoforms in T2DM and liver diseases. Additionally, we explore the collective knowledge on plant-based drug compounds that regulate HSP90 isoform targets, highlighting their potential in treating T2DM-associated liver diseases. Furthermore, this review focuses on the computational systems' biology and next-generation sequencing technology approaches that are used to unravel the potential medicine for the treatment of pleiotropy of these 2 diseases and to further elucidate the mechanism.</description><identifier>ISSN: 1559-0305</identifier><identifier>EISSN: 1559-0305</identifier><identifier>DOI: 10.1007/s12033-024-01251-1</identifier><identifier>PMID: 39162909</identifier><language>eng</language><publisher>Switzerland</publisher><ispartof>Molecular biotechnology, 2024-08</ispartof><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-8915-3542</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39162909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nithyasree, V</creatorcontrib><creatorcontrib>Magdalene, P</creatorcontrib><creatorcontrib>Praveen Kumar, P K</creatorcontrib><creatorcontrib>Preethi, J</creatorcontrib><creatorcontrib>Gromiha, M Michael</creatorcontrib><title>Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases</title><title>Molecular biotechnology</title><addtitle>Mol Biotechnol</addtitle><description>Non-alcoholic fatty acid liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) are the fatal liver diseases which encompass a spectrum of disease severity associated with increased risk of type 2 diabetes mellitus (T2DM), a metabolic disorder. Heat shock proteins serve as markers in early prognosis and diagnosis of early stages of liver diseases associated with metabolic disorder. This review aims to comprehensively investigate the significance of HSP90 isoforms in T2DM and liver diseases. Additionally, we explore the collective knowledge on plant-based drug compounds that regulate HSP90 isoform targets, highlighting their potential in treating T2DM-associated liver diseases. Furthermore, this review focuses on the computational systems' biology and next-generation sequencing technology approaches that are used to unravel the potential medicine for the treatment of pleiotropy of these 2 diseases and to further elucidate the mechanism.</description><issn>1559-0305</issn><issn>1559-0305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNUMlOwzAUtBCIlsAPcEA-cgm8ZydOfKzK0kpFbOUc2YkjjNIk5Dmg_j2VKBKnmcNsGsbOEa4QILsmFCBlDCKJAUWKMR6wKaapjkFCeviPT9gJ0QeAwDSRx2wiNSqhQU_Z80vXON7VfPH6pIH7lq-3veOC33hjXXDEH1zT-DASN23Fl4H4jKgrvQm-a_m3D-985b_csDOQM-TolB3VpiF3tseIvd3drueLePV4v5zPVnGPCYZYQWWzXKoatbNSpwrAgqhEKbPEiRpFDiorZZ0JWwoEI4xRVmsElLo2SSYjdvmb2w_d5-goFBtP5W6saV03UiFBJ7lQ-a4kYhd76Wg3rir6wW_MsC3-bpA_ik1clg</recordid><startdate>20240820</startdate><enddate>20240820</enddate><creator>Nithyasree, V</creator><creator>Magdalene, P</creator><creator>Praveen Kumar, P K</creator><creator>Preethi, J</creator><creator>Gromiha, M Michael</creator><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8915-3542</orcidid></search><sort><creationdate>20240820</creationdate><title>Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases</title><author>Nithyasree, V ; Magdalene, P ; Praveen Kumar, P K ; Preethi, J ; Gromiha, M Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-60db7836f19eb395600b02d2c374e2f128067c3f72bc210a2aa6b9910139fa473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nithyasree, V</creatorcontrib><creatorcontrib>Magdalene, P</creatorcontrib><creatorcontrib>Praveen Kumar, P K</creatorcontrib><creatorcontrib>Preethi, J</creatorcontrib><creatorcontrib>Gromiha, M Michael</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nithyasree, V</au><au>Magdalene, P</au><au>Praveen Kumar, P K</au><au>Preethi, J</au><au>Gromiha, M Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases</atitle><jtitle>Molecular biotechnology</jtitle><addtitle>Mol Biotechnol</addtitle><date>2024-08-20</date><risdate>2024</risdate><issn>1559-0305</issn><eissn>1559-0305</eissn><abstract>Non-alcoholic fatty acid liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) are the fatal liver diseases which encompass a spectrum of disease severity associated with increased risk of type 2 diabetes mellitus (T2DM), a metabolic disorder. Heat shock proteins serve as markers in early prognosis and diagnosis of early stages of liver diseases associated with metabolic disorder. This review aims to comprehensively investigate the significance of HSP90 isoforms in T2DM and liver diseases. Additionally, we explore the collective knowledge on plant-based drug compounds that regulate HSP90 isoform targets, highlighting their potential in treating T2DM-associated liver diseases. Furthermore, this review focuses on the computational systems' biology and next-generation sequencing technology approaches that are used to unravel the potential medicine for the treatment of pleiotropy of these 2 diseases and to further elucidate the mechanism.</abstract><cop>Switzerland</cop><pmid>39162909</pmid><doi>10.1007/s12033-024-01251-1</doi><orcidid>https://orcid.org/0000-0002-8915-3542</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1559-0305
ispartof Molecular biotechnology, 2024-08
issn 1559-0305
1559-0305
language eng
recordid cdi_proquest_miscellaneous_3094826878
source SpringerNature Journals
title Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A09%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20HSP90%20in%20Type%202%20Diabetes%20Mellitus%20and%20Its%20Association%20with%20Liver%20Diseases&rft.jtitle=Molecular%20biotechnology&rft.au=Nithyasree,%20V&rft.date=2024-08-20&rft.issn=1559-0305&rft.eissn=1559-0305&rft_id=info:doi/10.1007/s12033-024-01251-1&rft_dat=%3Cproquest_pubme%3E3094826878%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3094826878&rft_id=info:pmid/39162909&rfr_iscdi=true